G2TW Bonds 9.5% 1989 Floating Rate (PCLOF)

Market Closed

10 Aug, 15:56

OTC PINK

0. 05

+1.4816%

9.02M Market Cap

- P/E Ratio

- Div Yield

11,600 Volume

0 Eps

$ 0.05

Previous Close

Add Transaction

Day Range

0.05 0.05

Year Range

0 0.12

Want to track PCLOF and more in your Portfolio? 🎯

Get Started For Free

Summary

PCLOF closed today higher at $0.05, an increase of 1.4816% from yesterday's close, completing a monthly increase of 7.6327% or $0. Over the past 12 months, PCLOF stock gained 35.2308%.

PCLOF is not paying dividends to its shareholders.

The last earnings report, released on May 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.

The stock of the company had never split.

The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

PCLOF Chart

G2TW Bonds 9.5% 1989 Floating Rate (PCLOF) FAQ

What is the stock price today?

The current price is $0.05.

On which exchange is it traded?

G2TW Bonds 9.5% 1989 Floating Rate is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is PCLOF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 9.02M.

Has G2TW Bonds 9.5% 1989 Floating Rate ever had a stock split?

No, there has never been a stock split.

G2TW Bonds 9.5% 1989 Floating Rate Profile

Specialty Retail Industry	Consumer Discretionary Sector	Marc Lustig CEO	OTC PINK Exchange	71716K101 CUSIP
CA Country	268 Employees	- Last Dividend	- Last Split	- IPO Date

Overview

PharmaCielo Ltd. is a prominent entity in the medicinal cannabis industry, with a robust operation that spans cultivation, processing, production, and supply of medicinal-grade cannabis extracts, tetrahydrocannabinol (THC), and related products. The company is distinctive for its comprehensive approach to the cannabis sector, serving a diverse clientele that includes health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies primarily in Canada and Colombia. Headquartered in Toronto, Canada, PharmaCielo distinguishes itself with its international operations and a strategic partnership with Benuvia Operations, LLC. This partnership is focused on manufacturing cGMP (Current Good Manufacturing Practice) pharmaceutical-grade CBD isolate and other related products, signaling PharmaCielo's commitment to quality and regulatory compliance in the burgeoning field of medicinal cannabis.

Products and Services

Medicinal-grade cannabis extracts: PharmaCielo specializes in producing high-quality cannabis extracts that meet medicinal-grade standards. These extracts are derived from carefully cultivated cannabis, ensuring that they contain the desired levels of cannabinoids for therapeutic use.
Tetrahydrocannabinol (THC) products: The company offers products containing THC, the psychoactive component of cannabis, for medical and therapeutic applications. These products are designed to meet the needs of patients requiring THC's specific benefits.
Telemedicine software: In addition to its cannabis-based products, PharmaCielo provides telemedicine software to facilitate remote healthcare services. This software enables health professionals to offer consultations and services to patients in remote or underserved areas, enhancing access to healthcare.
cGMP pharmaceutical-grade CBD isolate: Through its strategic partnership with Benuvia Operations, LLC, PharmaCielo manufactures cGMP pharmaceutical-grade CBD isolate. This product adheres to stringent quality controls and is intended for use in various therapeutic and medicinal applications.

Contact Information

Address: 82 Richmond Street East

Phone: +1 416 532 5063

Website: https://www.pharmacielo.com

Blog Affiliate Program About Terms Privacy Help Contact Us